Investors love the 12-month forecast for Amarin Corp(AMRN)

close up photo of a person pouring mixture on a tube

Market Data

Amarin Corp(AMRN) is a stock of interest due to the large impact the company has on the market. Here at Wall Street Facts we only cover the best stocks so make sure you check out our other articles. Today we will be diving deep into all of the essential information you need to know about AMRN. We will be studying the movement so you can make the best decision as an investor. The stock has moved downwards today by 3.45%. The high for today is 6.28 and today’s low is 6.04. This information is critical in deciding whether this investment is risky or not. We can see the stock is trending downwards, which means the volume of people selling this stock is greater than people buying it.

Company Description

Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. Its product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. It has developed and markets Vascepa capsules through wholesale. The company was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Stock Forecast

As an investor, you can get an idea of where the stock is trending by the forecast. In this case, the high forecast for Amarin Corp is $19.00 and the low forecast is $10.00. Overall, Amarin Corp is in great shape going forward. They have a strong market cap of $2.42B and a very bright future ahead of them.

Leave a Reply

%d bloggers like this: